Ratings WalkMe Ltd.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
7.79 ^USD	+0.65%		-1.77%	-26.99%

04-17	Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating	MT
04-15	Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating	MT

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Thanks to a sound financial situation, the firm has significant leeway for investment.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
WALKME LTD.	-26.99%	712M		-
ZSCALER, INC.	-20.40%	25.82B		C
MONDAY.COM LTD.	-0.47%	9.29B		-
KPIT TECHNOLOGIES LIMITED	-1.30%	4.86B		C
TRAFFIC CONTROL TECHNOLOGY CO., LTD.	-2.88%	475M	-	-
XPERI INC.	-3.36%	472M		-
INSYDE SOFTWARE CORP.	-8.48%	278M	-	-
ZHENGZHOU TIAMAES TECHNOLOGY CO.,LTD	-15.82%	249M	-	-
HANGZHOU HOPECHART IOT TECHNOLOGY CO.,LTD	-38.51%	202M	-	-
ELLIPTIC LABORATORIES ASA	-8.57%	150M		-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality